Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference
SEATTLE, Sept. 10, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.
The presentation with slides will be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.
Annual Rodman & Renshaw Global Investment Conference
CTI presentation: Tuesday, September 11, 2012
10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific
Starlight North, Waldorf-Astoria Hotel
SOURCE Cell Therapeutics, Inc.
More by this Source
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI® (pixantrone) in Germany
Dec 04, 2013, 01:30 ET
Cell Therapeutics Receives $5 Million Milestone Payment for TRISENOX®
Dec 02, 2013, 01:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.